Some important aminoacid metabolites, commonly used as
nutritional supplements, such as L-carnitine11 or creatine,12
have structural features suitable for their detection by 6. There-
fore, we tested 10À4 M solutions of 6 with their aqueous
solutions. As metabolites were added, the yellow fluorescence
was clearly shifted to blue in the presence of two or more
equivalents of L-carnitine or creatine. There was no change in
the presence of even 3 equivalents of sarcosine or creatinine
(Fig. 2). Fluorescent titration of 6 (10À4 M in DMSO) and
aqueous creatine or L-carnitine solutions showed decreasing of
the intensity of emission as metabolites were added. Titration
profiles fitted a 1 : 1 binding model for creatine and a 2 : 1
binding model for L-carnitine, from which binding constants
were calculated (Table 2). Job’s plot analysis of fluorescence
titrations with L-carnitine revealed a maximum at a 66% mole
fraction, in accord with the proposed 2 : 1 binding stoichio-
the distance between the terminal ammonium and the carboxylate
groups. At lexc = 390 nm only decreasing of the yellow emission
was measured but by tuning the lexc to 366 nm the blue
fluorescence was seen (under the TLC UV-light) or measured in
the spectrofluorometer (see ESIw). Moreover, the sensitivity to
the detected metabolites is preserved in a large extension by
performing the experiments in the presence of several equivalents
of the undetected aminoacids (see ESIw), thus making the system
suitable for the quantitative detection of o-aminoacids and their
metabolites from nutritional supplements, and some important
drugs related to them, such as pregabalin or gabapentin, from
their pharmaceutical formulations.
We gratefully acknowledge financial support from the
Ministerio de Ciencia e Innovacio
12631-BQU), Junta de Castilla y Leo
cion y Cultura y Fondo Social Europeo (Projects BU023A09
´
n, Spain (Project CTQ2009-
´
n, Consejerıa de Educa-
´
´
metry (see ESIw). We calculated detection limits of 10À4
M
and GR170).
solutions of 6 in DMSO, calculated in fluorescence emission
by the blank variability method,13 and selected metabolites
in water, that were 1.93 Â 10À7 M for L-asparagine, 3.09 Â
10À6 M for GABA and 1.38 Â 10À6 M for L-carnitine. We also
Notes and references
1 (a) C. Sonnichsen, B. M. Reinhard, J. Liphardt and
¨
A. P. Alivisatos, Nat. Biotechnol., 2005, 23, 741; (b) G. L. Liu,
Y. Yin, S. Kunchakarra, B. Mukherjee, D. Gerion, S. D. Jett,
D. G. Bear, J. W. Gray, A. P. Alivisatos, L. P. Lee and F. F. Chen,
Nat. Nanotechnol., 2006, 1, 47.
2 Y. S. Chi, H. R. Byon, B. S. Lee, B. Kong, H. C. Choi and
I. S. Choi, Adv. Funct. Mater., 2008, 18, 3395.
3 C. Steinhauer, R. Jungmann, T. L. Sobey, F. C. Simmel and
P. Tinnefeld, Angew. Chem., Int. Ed., 2009, 48, 8870.
4 M. J. Crossley and P. Thordarson, Angew. Chem., Int. Ed., 2002,
41, 1709.
5 (a) Review: X. Chen, Y. Zhou, X. Peng and J. Yoon, Chem. Soc.
Rev., 2010, 39, 2120; recent examples: (b) B. Zhu, X. Zhang, Y. Li,
P. Wang, H. Zhangb and X. Zhuang, Chem. Commun., 2010, 46,
5710; (c) N. Shao, J. Jin, H. Wang, J. Zheng, R. Yang, W. Chan
and Z. Abliz, J. Am. Chem. Soc., 2010, 132, 725.
6 Some examples are reviewed in: (a) L. Pu, Chem. Rev., 2004, 104,
1687; lysine: (b) D. M. Bailey, A. Hennig, V. D. Uzunova and
W. M. Nau, Chem.–Eur. J., 2008, 14, 6069; glutamate:
(c) M. Riskin, R. Tel-Vered, M. Frasconi, N. Yavo and
I. Willner, Chem.–Eur. J., 2010, 16, 7114; tryptophan:
(d) L. Yang, S. Qin, X. Su, F. Yang, J. You, C. Hu, R. Xie and
J. Lan, Org. Biomol. Chem., 2010, 8, 339; (e) Y. Ling, W. Wang
and A. E. Kaifer, Chem. Commun., 2007, 610; serine: (f) H. Wang,
W.-H. Chan and A. W. M. Lee, Org. Biomol. Chem., 2008, 6, 929.
7 (a) Q.-S. Lu, L. Dong, J. Zhang, J. Li, L. Jiang, Y. Huang, S. Qin,
C.-W. Hu and X.-Q. Yu, Org. Lett., 2009, 11, 669; (b) Y. K. Kim,
H. N. Lee, N. J. Singh, H. J. Choi, J. Y. Xue, K. S. Kim, J. Yoon
and M. H. Hyun, J. Org. Chem., 2008, 73, 301; (c) C. Wolf, S. Liu
and B. C. Reinhardt, Chem. Commun., 2006, 4242.
1
carried out H NMR titration experiments of a 10À1 M solu-
tion of 6 with b-alanine, both in DMSO-d6. By addition of
increasing amounts of b-alanine, the two urea NH signals at
d 8.8 and 6.7 moved to a lower field and progressively disappeared
as the H-bonds were formed. The aromatic signals became
more complicate but their chemical shifts remained unchanged
(see ESIw). Apparently, formation of the 1 : 1 and 2 : 1 complexes
affected the urea protons and restricted rotation of the
aromatic rings. With this in mind, we optimized the geometries
of 1 : 1 complexes between 6 and zwitterionic GABA or
pregabalin, stabilized by 3 molecules of DMSO, at the ONIOM
(B3LYP/6-31G*:AM1) level by using GAUSSIAN 03 (Fig. 5 for
the 6 : GABAÁ3DMSO complex).14
The presence of at least 3 molecules of DMSO was necessary
in both cases to stabilize the zwitterionic structures of amino-
acids, otherwise additional hydrogen bonds between the
ammonium and the carboxylate groups were produced during
the calculation, with proton transfer from the ammonium to
the carboxylate groups. The structures converged to stationary
points having four hydrogen bonds between the urea NH
protons and the carboxylate groups that agreed with the
1H-NMR titration results and accounted for the interactions
that gave rise to the molecular ruler effect.
8 Reviews: (a) V. Amendola, L. Fabbrizzi and L. Mosca, Chem. Soc.
Rev., 2010, 39, 3889; (b) A.-F. Li, J.-H. Wang, F. Wang and
Y.-B. Jiang, Chem. Soc. Rev., 2010, 39, 3729; (c) R. M. Duke,
E. B. Veale, F. M. Pfeffer, P. E. Kruger and T. Gunnlaugsson,
Chem. Soc. Rev., 2010, 39, 3936.
In summary, we have prepared a fluorescent probe for
o-aminoacid derivatives that behaved as a molecular ruler, thus
changing the yellow fluorescent emission into blue as a function of
9 (a) R. B. Silverman, Angew. Chem., Int. Ed., 2008, 47, 3500;
(b) O. Bassas, J. Huuskonen, K. Rissanen and A. M. P. Koskinen,
Eur. J. Org. Chem., 2009, 1340.
10 (a) P. G. Vasudev, S. Chatterjee, N. Shamala and P. Balaram, Acc.
Chem. Res., 2009, 42, 1628; (b) H. Zhao and Z. Guo, Drug
Discovery Today, 2009, 14, 516.
11 H. Bakirci and W. M. Nau, Adv. Funct. Mater., 2006, 16, 237.
12 S. Goswami, S. Jana, A. Hazra, H.-K. Fun, S. Anjum and
A.-u. Rahman, CrystEngComm, 2006, 8, 712.
13 D. L. Massart, B. G. M. Vandeginste, L. M. C. Buydens, S. De Jong,
P. J. Lewi and J. Smeyers-Verbeke, Handbook of Chemometrics and
Qualimetrics: Part A, Elsevier, Amsterdam, The Netherlands, 1997,
ch. 13, p. 379.
14 M. J. Frisch and J. A. Pople, Gaussian 03, Revision C.02, Gaussian,
Inc., Wallingford CT, 2004 (See ESIw for the complete reference).
Fig. 5 Optimized geometry of the 6 : GABAÁ3DMSO complex at the
ONIOM (B3LYP/6-31G*:AM1) in GAUSSIAN 03.
c
This journal is The Royal Society of Chemistry 2011
Chem. Commun., 2011, 47, 3183–3185 3185